-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Mereo BioPharma Group, Maintains $6 Price Target

Benzinga·12/18/2025 10:07:58
语音播报
BTIG analyst Julian Harrison reiterates Mereo BioPharma Group (NASDAQ:MREO) with a Buy and maintains $6 price target.